Department of Radiation Oncology, RWTH Aachen University, Pauwelsstrasse 30, 52072, Aachen, Germany.
Department of Radiation Oncology, MediClin Robert Janker Klinik, Villenstr. 8, 53129, Bonn, Germany.
Qual Life Res. 2021 Feb;30(2):437-443. doi: 10.1007/s11136-020-02639-7. Epub 2020 Oct 9.
Analysis of quality of life changes after radiotherapy with focus on the impact of time after treatment and prescription dose.
Consecutive patients were treated with doses from 70.2/1.8 Gy (n = 206) to 72/1.8-2.0 Gy (n = 176) in a single centre and surveyed using the Expanded Prostate Cancer Index Composite questionnaire.
Urinary and bowel bother scores decreased 1 / 3 / 6 points and 7 / 7 / 9 points on average 1 / 5 / 10 years after RT in comparison to baseline scores. The rate of urinary (need of pads in 8% vs. 15% before vs. 10 years after RT; p = 0.01) and bowel (uncontrolled leakage of stool in 5% vs. 12% before vs. 10 years after RT; p < 0.01) incontinence, as well as rectal bleeding (4% vs. 8% before vs. 10 years after RT; p = 0.05) increased. Sexual function scores decreased (erections sufficient for intercourse in 36% vs. 12% before vs. 10 years after RT; p < 0.01). A higher dose had a statistically significant impact on urinary bother and stool incontinence, but also tended to decrease urinary continence. Age and comorbidities did not have an influence on score changes, but on baseline urinary function/bother and baseline sexual function.
Apart from an increasing rate of erectile dysfunction, urinary and bowel incontinence rates increased with increasing follow-up period. A higher dose was found to be associated with increased urinary problems and larger stool incontinence rates. Age and comorbidities were found to be relevant for baseline scores, but not for score changes.
分析放疗后生活质量的变化,重点关注治疗后时间和处方剂量的影响。
在一个中心,连续的患者接受了从 70.2/1.8 Gy(n=206)到 72/1.8-2.0 Gy(n=176)的剂量治疗,并使用扩展前列腺癌指数综合问卷进行了调查。
与基线评分相比,在 RT 后 1/5/10 年,尿和肠困扰评分平均分别降低了 1/3/6 分和 7/7/9 分。尿失禁(使用尿垫的比例分别为 8%、15%和 10 年后 RT;p=0.01)和肠失禁(无法控制的粪便泄漏的比例分别为 5%、12%和 10 年后 RT;p<0.01)以及直肠出血(4%、8%和 10 年后 RT;p=0.05)的发生率增加。性功能评分下降(勃起足以进行性交的比例分别为 36%、12%和 10 年后 RT;p<0.01)。更高的剂量对尿困扰和大便失禁有统计学显著影响,但也倾向于降低尿控。年龄和合并症对评分变化没有影响,但对基线尿功能/困扰和基线性功能有影响。
除了勃起功能障碍的发生率增加外,随着随访时间的延长,尿失禁和肠失禁的发生率也在增加。更高的剂量与更多的尿问题和更大的大便失禁率有关。年龄和合并症与基线评分相关,但与评分变化无关。